SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI)

CUSIP: 09073Q204

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / SPON ADS NEW
Total 13F shares
409,939
Share change
-52,494
Total reported value
$212,661
Price per share
$0.52
Number of holders
12
Value change
-$27,303
Number of buys
5
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 09073Q204?
CUSIP 09073Q204 identifies SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) as of Q1 2024

As of 31 Mar 2024, SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 409,939 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, RHUMBLINE ADVISERS, MORGAN STANLEY, UBS Group AG, Credit Agricole S A, Main Street Group, LTD, and Aspire Private Capital, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.